4.6 Article

Efficacy of focal high-dose-rate brachytherapy in the treatment of patients diagnosed with low or favourable intermediate-risk prostate cancer-a protocol for a randomised controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy

Yoh Matsuoka et al.

Summary: In low- to intermediate-risk prostate cancer, focal brachytherapy (FB) patients achieved better genitourinary function compared to pair-matched radical prostatectomy (RP) patients, and there were no significant differences in salvage therapy needed between the two treatment cohorts.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Article Oncology

Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial

Mark Corkum et al.

Summary: High dose-rate brachytherapy as monotherapy for prostate cancer is well tolerated with minimal impact on health related quality of life. The study found subtle differences in toxicity and quality of life changes between the two fractionation schemes.

RADIOTHERAPY AND ONCOLOGY (2021)

Review Urology & Nephrology

Focal therapy for prostate cancer: Making the punishment fit the crime

F. Aoun et al.

Summary: Focal therapy is a treatment option for localized prostate cancer, suitable for small to medium-sized lesions. Various technologies such as high-intensity focal ultrasound, cryotherapy, and focal laser ablation have shown promising results in terms of survival rates, functional outcomes, and oncologic outcomes. Further research is needed to better understand the long-term efficacy of these techniques.

PROGRES EN UROLOGIE (2021)

Article Andrology

Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution

Elliot Anderson et al.

Summary: The study evaluated the dosimetry, toxicity, and oncological outcomes of men receiving lesion-targeted focal LDR brachytherapy for low to intermediate risk PCa. The results showed that focal LDR brachytherapy is associated with a favorable toxicity profile and a high rate of control of significant PCa at 12-18 months post-treatment.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Article Oncology

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer

Hiroaki Kunogi et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2020)

Review Oncology

Contemporary treatments in prostate cancer focal therapy

Michael Ahdoot et al.

CURRENT OPINION IN ONCOLOGY (2019)

Article Oncology

MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility study

Max Peters et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Review Urology & Nephrology

New and Established Technology in Focal Ablation of the Prostate: A Systematic Review

Massimo Valerio et al.

EUROPEAN UROLOGY (2017)

Article Urology & Nephrology

THE AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA

Michael J. Barry et al.

JOURNAL OF UROLOGY (2017)

Review Urology & Nephrology

The evolution of brachy therapy for prostate cancer

Nicholas G. Zaorsky et al.

NATURE REVIEWS UROLOGY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo dosimetry in brachytherapy

Kari Tanderup et al.

MEDICAL PHYSICS (2013)

Article Medicine, General & Internal

Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer

Matthew J. Resnick et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Radical Prostatectomy versus Observation for Localized Prostate Cancer

Timothy J. Wilt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Oncology

Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005

H. Gilbert Welch et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)

Review Urology & Nephrology

Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities

Scott E. Eggener et al.

JOURNAL OF UROLOGY (2007)

Article Oncology

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century

M. P. Coleman et al.

ANNALS OF ONCOLOGY (2003)